Patents by Inventor Brian Elenbaas

Brian Elenbaas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to the Human Prolactin Receptor
    Publication number: 20090017044
    Abstract: This invention provides antibodies to the prolactin receptor, particularly the human prolactin receptor. Preferred antibodies are capable of blocking prolactin binding to the prolactin receptor, inhibiting signaling through the prolactin receptor, and/or inhibiting proliferation of cancer cells induced by prolactin. Also provided are nucleic acids encoding the antibodies, vectors and host cells comprising the nucleic acids, and uses of the antibodies and nucleic acids.
    Type: Application
    Filed: April 30, 2008
    Publication date: January 15, 2009
    Applicant: BIOGEN IDEC MA INC.
    Inventors: Brian Elenbaas, Matthew B. Jarpe, Steven D. Miklasz, Stephen E. Fawell
  • Antibodies to the human prolactin receptor
    Patent number: 7422899
    Abstract: This invention provides antibodies to the prolactin receptor, particularly the human prolactin receptor. Preferred antibodies are capable of blocking prolactin binding to the prolactin receptor, inhibiting signaling through the prolactin receptor, and/or inhibiting proliferation of cancer cells induced by prolactin. Also provided are nucleic acids encoding the antibodies, vectors and host cells comprising the nucleic acids, and uses of the antibodies and nucleic acids.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: September 9, 2008
    Assignee: Biogen Idec MA Inc.
    Inventors: Brian Elenbaas, Matthew B Jarpe, Steven D. Miklasz, Stephen E. Fawell
  • Antibodies to the Human Prolactin Receptor
    Publication number: 20070269438
    Abstract: This invention provides antibodies to the prolactin receptor, particularly the human prolactin receptor. Preferred antibodies are capable of blocking prolactin binding to the prolactin receptor, inhibiting signaling through the prolactin receptor, and/or inhibiting proliferation of cancer cells induced by prolactin. Also provided are nucleic acids encoding the antibodies, vectors and host cells comprising the nucleic acids, and uses of the antibodies and nucleic acids.
    Type: Application
    Filed: October 4, 2006
    Publication date: November 22, 2007
    Inventors: Brian Elenbaas, Matthew Jarpe, Steven Miklasz, Stephen Fawell